The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up by +0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.10%....
SAN DIEGO , Dec. 4, 2025 /PRNewswire/ --Â Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary injunction ordering...
The S&P 500 Index ($SPX ) (SPY ) is down by -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.28%. December E-mini S&P futures...
The S&P 500 Index ($SPX ) (SPY ) is down up by -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.38%. December E-mini S&P...
SAN DIEGO , Nov. 25, 2025 /PRNewswire/ --Â Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host...
Royalty revenue contribution expected to begin as early as 2030
SAN DIEGO and UTRECHT, The Netherlands and CAMBRIDGE, Mass. , Nov. 17, 2025 /PRNewswire/ -- Merus N.V. Â (Nasdaq: MRUS) ("Merus"), an oncology company developing innovative, full-length multispecific...
DARZALEX Faspro® is co-formulated with Halozyme's ENHANZE® drug delivery technology
SAN DIEGO , Nov. 6, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), today announced the pricing of $650 million aggregate principal amount of 0% convertible...
SAN DIEGO , Nov. 5, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company"), today announced that it intends to offer, subject to market conditions and other...